Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor cells

Rosario Yerbes(Instituto de Salud Carlos III), Carmen Palacios(Centro Andaluz de Biología Molecular y Medicina Regenerativa)

Cell Death and Disease

October 27, 2022

10.1038/s41419-022-05346-y

Cited by 17

Related Papers

Control of FLIPL expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells

|Cell Death and Differentiation|2012|16

Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosis

|Oncotarget|2017|7

Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells

|Cells|2023|6

Activation of the integrated stress response and loss of cFLIPL under glutamine limitation induce IL-8 gene expression and secretion in glutamine-dependent tumor cells

|Cell Death Discovery|2025|2